Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Shares Shorted: Short Interest Up 979.7% in October

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) was the recipient of a large increase in short interest in October. As of October 15th, there was short interest totaling 1,348,635 shares, an increase of 979.7% from the September 30th total of 124,913 shares. Based on an average daily volume of 837,048 shares, the days-to-cover ratio is currently 1.6 days. Currently, 0.1% of the company’s stock are sold short.

Coloplast A/S Price Performance

CLPBY stock opened at $7.24 on Tuesday. The company has a quick ratio of 0.94, a current ratio of 1.56 and a debt-to-equity ratio of 1.51. Coloplast A/S has a 52-week low of $5.64 and a 52-week high of $9.70. The stock’s 50 day moving average is $6.78 and its two-hundred day moving average is $6.86. The company has a market capitalization of $16.32 billion, a PE ratio of 38.11, a P/E/G ratio of 2.61 and a beta of 0.21.

Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last released its earnings results on Tuesday, August 18th. The company reported $0.10 EPS for the quarter, meeting the consensus estimate of $0.10. Coloplast A/S had a return on equity of 39.27% and a net margin of 9.68%. The company had revenue of $1.14 billion during the quarter, compared to analysts’ expectations of $1.11 billion. Analysts predict that Coloplast A/S will post 0.40 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

(Get Free Report)

Coloplast A/S is a Denmark-based medical technology company that develops, manufactures and markets products designed to help people manage intimate health conditions. Its core businesses include ostomy care, continence care, wound and skin care, and interventional urology. The company’s products are used by patients and healthcare professionals in hospitals, clinics and home-care settings.

Coloplast was founded in Denmark in 1957 after nurse Elise Sørensen helped develop an adhesive ostomy bag for her sister, who had undergone surgery.

Recommended Stories

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.